SOURCE: Equity News Circuit

Equity News Circuit

May 22, 2013 08:20 ET

Free Research Reports on BIIB, CCL, KMX and SKS Issued by the Paragon Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwired - May 22, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.

Biogen Idec Inc. (NASDAQ: BIIB) shares traded in the range of $226.00 to $234.20 Tuesday on volume of over 1.0 million shares traded. The company reported Plegridy, its injectable multiple sclerosis drug, to the FDA for market approval. Shares of Biogen Idec have gained approximately 58.0 percent year-to-date.

Find out more about Biogen Idec including full access to the free equity report at:

Carnival Corporation (NYSE: CCL) shares declined over 4.0 percent on volume of over 20.0 million shares traded Tuesday. The company announced that it now expects net revenues for the full year 2013 to be down 2 percent to 3 percent, compared to their previous guidance of flat revenues for the year.

Find out more about Carnival including full access to the free equity report at:

CarMax, Inc. (NYSE: KMX) shares have gained approximately 28.0 percent year-to-date. William Blair analyst Sharon Zackfia has recently downgraded the company's rating to "market perform" from "outperform". "Admittedly, our downgrade could be early, as absolute sales trends remain strong so far in the May quarter," stated Zackfia in a recent note to investors.

Find out more about CarMax including full access to the free equity report at:

Saks Inc. (NYSE: SKS) shares spiked over 10.0 percent on volume of nearly 7.0 million shares traded Tuesday. The company reported same-store sales for the fiscal first quarter increased 5.9 percent, which was on top of a 4.8 percent increase in the year ago quarter. Shares of Saks have gained approximately 28.0 percent year-to-date.

Find out more about Saks including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information